AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Edivone 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

PRM Life Sciences Pvt Ltd

Salt Composition

Edaravone (1.5mg)

Overview Edivone 1.5mg Injection

For amyotrophic lateral sclerosis (ALS), a debilitating neuromuscular disease, Edivone 1.5mg Injection offers therapeutic intervention by slowing neurological deterioration. This antioxidant medication combats nerve damage, potentially mitigating disease advancement. Administered intravenously by a healthcare provider—never self-injected—it's reserved for situations where oral intake is infeasible. Adhere strictly to your physician's prescribed dosage and schedule; if a dose is missed, administer it upon recollection. Commonly reported adverse effects include headaches, ecchymosis, and gait abnormalities. Localized injection-site reactions (pain, erythema, edema) may also occur but are typically transient and self-limiting. Persistent or bothersome side effects warrant medical consultation. Should an allergic response (pruritus, lip/tongue/facial swelling) develop, seek immediate medical care.

Primary Ingredients of Edivone 1.5mg Injection

No text provided to rephrase.

Uses of Edivone 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Edivone 1.5mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Edivone 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Edivone 1.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Edivone 1.5mg Injection works:

Edivone 1.5mg Injection, an antioxidant medication, offers neuroprotective and cognitive-enhancing benefits. Its mechanism involves mitigating neuronal damage from free radical attack, thereby delaying ALS symptom advancement. This effect is achieved by restoring equilibrium between free radicals and antioxidants within the brain, reducing overall oxidative stress.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Edivone 1.5mg Injection is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Edivone 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Edivone 1.5mg Injection use while breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Edivone 1.5mg Injection's impact on driving ability is undetermined. Refrain from driving should you experience symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Edivone 1.5mg Injection to individuals with renal impairment. Seek medical advice from your physician.

LiverLiverCAUTION

Patients with severe hepatic impairment should receive Edivone 1.5mg Injection with careful monitoring; dosage modification may be necessary. Consult a physician for guidance. Data on Edivone 1.5mg Injection use in such patients is limited. Dosage alterations are not advised for individuals exhibiting mild to moderate liver dysfunction.

What if you forget to take Edivone 1.5mg Injection :

NA

Facts to Know About Edivone 1.5mg Injection

LabelValue
Chemical Type Pyrazolone Derivative
Developing Habits No.
Treatment Category Neuroscience Central Nervous System
Behavioral Class Cognitive enhancer

FAQs on Edivone 1.5mg Injection

Edivone 1.5mg Injection may commonly cause confusion, headache, and gait disturbances. Less frequent side effects include skin rash or itching, breathing problems (shortness of breath, chest tightness, wheezing, cough, particularly in asthmatics), and fungal infections.
Edivone 1.5mg Injection, an intravenous solution, is administered by a healthcare professional over one hour in a medical setting. Initially, it's given daily for the first 14 days of a 28-day treatment cycle. Subsequent cycles involve daily administration for the first 10 days of a 28-day cycle. Dosage frequency is determined by your doctor based on your individual response.
Edivone 1.5mg Injection treats amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease causing muscle weakness and atrophy due to the gradual death of motor neurons. It works by slowing the progression of nerve damage, thus mitigating ALS symptom worsening.
Tell your doctor or pharmacist if you're allergic to edaravone, sodium bisulfite, any other medicines, or any Edivone 1.5mg Injection ingredients. Before starting edaravone, disclose all medications, vitamins, and supplements you're taking or plan to take; your doctor may adjust dosages or monitor you for side effects. Inform your doctor about any history of asthma, and if you're pregnant, plan to become pregnant, or are breastfeeding. Contact your doctor immediately if you become pregnant during treatment.
While the preventability of ALS remains unproven due to a lack of supporting studies, reducing exposure to known risk factors may lessen the likelihood of developing the disease. These risk factors include smoking and exposure to pesticides and insecticides; military service has also been identified as a potential risk factor.
People of Caucasian, non-Hispanic descent are most frequently diagnosed with ALS. Between 5% and 10% of cases are inherited (familial). Onset can occur at any age, though symptoms typically appear between ages 55 and 75. Men are slightly more prone than women, but this disparity diminishes with age. Research indicates military veterans may have a 1.5 to 2 times higher risk, potentially due to wartime toxin exposure.
Exposure to toxins from warfare or intense physical exertion may increase the risk of ALS among veterans and athletes, according to researchers.
ALS often begins with subtle muscle problems: twitches in the limbs or tongue, cramps, stiffness, and weakness affecting an arm, leg, neck, or diaphragm. Speech may become slurred or nasal, and swallowing difficult. Many first notice hand or arm weakness, hindering simple actions like buttoning a shirt or turning a key. Alternatively, leg weakness can be the initial symptom, leading to clumsiness, tripping, or stumbling.
Edivone 1.5mg Injection
419
MRP 485
13% off